Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys

Cell Transplantation

Volumn 22, Issue 5, 2013, Pages 831-838

  Emborg, Marina E ^a,b   Zhang, Zhijian ^c   Joers, Valerie ^a   Brunner, Kevin ^a   Bondarenko, Viktorya ^a   Ohshima, Sachiko ^a   Zhang, Su Chun ^b,c  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cell differentiation; Cell transplantation; Dopamine (DA); Human embryonic stem (hES) cells; Immune rejection; Parkinson's disease (PD)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CD45 ANTIGEN; CD68 ANTIGEN; CYCLOSPORIN A; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; NEURON SPECIFIC NUCLEAR PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG BLOOD LEVEL; EMBRYO; EMBRYONIC STEM CELL; EXPERIMENTAL MONKEY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NERVE CELL CULTURE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL DENSITY; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; RHESUS MONKEY; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; XENOGRAFT;

ACETYLTRANSFERASES; ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; FEMALE; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENTIVIRUS; MACACA MULATTA; MPTP POISONING; NERVE TISSUE PROTEINS; NESTIN; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MACACA MULATTA;

EID: 84876348834     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X647144     Document Type: Article

References (28)

1. Behrstock, S.; Ebert, A. D.; Klein, S.; Schmitt, M.; Moore, J. M.; Svendsen, C. N. Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant. 17:753-762; 2008.
2. Bezard, E.; Brotchie, J. M.; Gross, C. E. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies. Nat. Rev. Neurosci. 2:577-588; 2001.
3. Drukker, M. Immunogenicity of human embryonic stem cells: Can we achieve tolerance? Springer Semin. Immunopathol. 26:201-213; 2004.
4. Emborg, M. E.; Ebert, A. D.; Moirano, J.; Peng, S.; Suzuki, M.; Capowski, E.; Joers, V.; Roitberg, B. Z.; Aebischer, P.; Svendsen, C. N. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Cell Transplant. 17:383-395; 2008.
5. Emborg, M. E.; Ma, S. Y.; Mufson, E. J.; Levey, A. I.; Taylor, M. D.; Brown, W. D.; Holden, J. E.; Kordower, J. H. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J. Comp. Neurol. 401:253-265; 1998.
6. Emborg, M. E.; Moirano, J.; Raschke, J.; Bondarenko, V.; Zufferey, R.; Peng, S.; Ebert, A. D.; Joers, V.; Roitberg, B.; Holden, J. E.; Koprich, J.; Lipton, J.; Kordower, J. H.; Aebischer, P. Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol. Dis. 36:303-311; 2009.
7. Emborg, M. E.; Moirano, J.; Schafernak, K. T.; Moirano, M.; Evans, M.; Konecny, T.; Roitberg, B.; Ambarish, P.; Mangubat, E.; Ma, Y.; Eidelberg, D.; Holden, J.; Kordower, J. H.; Leestma, J. E. Basal ganglia lesions after MPTP administration in rhesus monkeys. Neurobiol. Dis. 23:281-289; 2006.
8. Emborg, M. E.; Shin, P.; Roitberg, B.; Sramek, J. G.; Chu, Y.; Stebbins, G. T.; Hamilton, J. S.; Suzdak, P. D.; Steiner, J. P.; Kordower, J. H. Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys. Exp. Neurol. 168:171-182; 2001.
9. Emborg-Knott, M. E.; Domino, E. F. MPTP-induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose. Exp. Neurol. 152:214-220; 1998.
10. Fitzpatrick, K. M.; Raschke, J.; Emborg, M. E. Cell-based therapies for Parkinson's disease: Past, present, and future. Antioxid. Redox. Signal. 11:2189-2208; 2009.
11. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:710-719; 2001.
12. Guillaume, D. J.; Johnson, M. A.; Li, X. J.; Zhang, S. C. Human embryonic stem cell-derived neural precursors develop into neurons and integrate into the host brain. J. Neurosci. Res. 84:1165-1176; 2006.
13. Halme, D. G.; Kessler, D. A. FDA regulation of stem-cellbased therapies. N. Engl. J. Med. 355:1730-1735; 2006.
14. Hargus, G.; Cooper, O.; Deleidi, M.; Levy, A.; Lee, K.; Marlow, E.; Yow, A.; Soldner, F.; Hockemeyer, D.; Hallett, P. J.; Osborn, T.; Jaenisch, R.; Isacson, O. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. USA 107:15921-15926; 2010.
15. Kriks, S.; Shim, J. W.; Piao, J.; Ganat, Y. M.; Wakeman, D. R.; Xie, Z.; Carrillo-Reid, L.; Auyeung, G.; Antonacci, C.; Buch, A.; Yang, L.; Beal, M. F.; Surmeier, D. J.; Kordower, J. H.; Tabar, V.; Studer, L. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011. [Epub ahead of print.]
16. Li, J. Y.; Englund, E.; Holton, J. L.; Soulet, D.; Hagell, P.; Lees, A. J.; Lashley, T.; Quinn, N. P.; Rehncrona, S.; Björklund, A.; Widner, H.; Revesz, T.; Lindvall, O.; Brundin, P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14:501-503; 2008.
17. Mendez, I.; Viñuela, A.; Astradsson, A.; Mukhida, K.; Hallett, P.; Robertson, H.; Tierney, T.; Holness, R.; Dagher, A.; Trojanowski, J. Q.; Isacson, O. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 14:507-509; 2008.
18. Olanow, C. W.; Goetz, C. G.; Kordower, J. H.; Stoessel, A. J.; Sossi, V.; Brin, M. F.; Shannon, K. M.; Nauert, G. M.; Perl, D. P.; Godbold, J.; Freeman, T. B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54:403-414; 2003.
19. Perrier, A. L.; Tabar, V.; Barberi, T.; Rubio, M. E.; Bruses, J.; Topf, N.; Harrison, N. L.; Studer, L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. U S A 101:12543-12548; 2004.
20. Roy, N. S.; Cleren, C.; Singh, S. K.; Yang, L.; Beal, M. F.; Goldman, S. A. Functional engraftment of human ES cellderived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12:1259-1268; 2006.
21. Suzuki, M.; McHugh, J.; Tork, C.; Shelley, B.; Klein, S. M.; Aebischer, P.; Svendsen, C. N. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2:e689; 2007.
22. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872; 2007.
23. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147; 1998.
24. Xia, X.; Zhang, Y.; Zieth, C. R.; Zhang, S. C. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 16:167-176; 2007.
25. Yan, Y.; Yang, D.; Zarnowska, E. D.; Du, Z.; Werbel, B.; Valliere, C.; Pearce, R. A.; Thomson, J. A.; Zhang, S. C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23:781-790; 2005.
26. Yang, D.; Zhang, Z. J.; Oldenburg, M.; Ayala, M.; Zhang, S. C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 26:55-63; 2008.
27. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz- Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; Slukvin, I. I.; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920; 2007.
28. Zhang, S. C.; Wernig, M.; Duncan, I. D.; Brustle, O.; Thomson, J. A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19:1129-1133; 2001.